232 related articles for article (PubMed ID: 30982554)
1. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
2. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
3. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
[No Abstract] [Full Text] [Related]
4. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer.
Wong YY; Hyde Z; McCaul KA; Yeap BB; Golledge J; Hankey GJ; Flicker L
PLoS One; 2014; 9(6):e99954. PubMed ID: 24949795
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D as a predictor of mortality and cardiovascular events: A 20-year study of a community-based cohort.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Clin Endocrinol (Oxf); 2018 Jan; 88(1):154-163. PubMed ID: 28949411
[TBL] [Abstract][Full Text] [Related]
6. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
McCullough ML; Zoltick ES; Weinstein SJ; Fedirko V; Wang M; Cook NR; Eliassen AH; Zeleniuch-Jacquotte A; Agnoli C; Albanes D; Barnett MJ; Buring JE; Campbell PT; Clendenen TV; Freedman ND; Gapstur SM; Giovannucci EL; Goodman GG; Haiman CA; Ho GYF; Horst RL; Hou T; Huang WY; Jenab M; Jones ME; Joshu CE; Krogh V; Lee IM; Lee JE; Männistö S; Le Marchand L; Mondul AM; Neuhouser ML; Platz EA; Purdue MP; Riboli E; Robsahm TE; Rohan TE; Sasazuki S; Schoemaker MJ; Sieri S; Stampfer MJ; Swerdlow AJ; Thomson CA; Tretli S; Tsugane S; Ursin G; Visvanathan K; White KK; Wu K; Yaun SS; Zhang X; Willett WC; Gail MH; Ziegler RG; Smith-Warner SA
J Natl Cancer Inst; 2019 Feb; 111(2):158-169. PubMed ID: 29912394
[TBL] [Abstract][Full Text] [Related]
7. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.
Vashi PG; Trukova K; Lammersfeld CA; Braun DP; Gupta D
Nutr J; 2010 Nov; 9():60. PubMed ID: 21092237
[TBL] [Abstract][Full Text] [Related]
8. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and cancer mortality in elderly women.
Wong G; Lim WH; Lewis J; Craig JC; Turner R; Zhu K; Lim EM; Prince R
BMC Cancer; 2015 Mar; 15():106. PubMed ID: 25884436
[TBL] [Abstract][Full Text] [Related]
11. Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women.
Chandler PD; Tobias DK; Wang L; Smith-Warner SA; Chasman DI; Rose L; Giovannucci EL; Buring JE; Ridker PM; Cook NR; Manson JE; Sesso HD
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29315215
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-Hydroxyvitamin D and Subsequent Cancer Incidence and Mortality: A Population-Based Retrospective Cohort Study.
Johnson CR; Dudenkov DV; Mara KC; Fischer PR; Maxson JA; Thacher TD
Mayo Clin Proc; 2021 Aug; 96(8):2157-2167. PubMed ID: 34353470
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006).
Freedman DM; Looker AC; Abnet CC; Linet MS; Graubard BI
Cancer Res; 2010 Nov; 70(21):8587-97. PubMed ID: 20847342
[TBL] [Abstract][Full Text] [Related]
14. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.
Schöttker B; Haug U; Schomburg L; Köhrle J; Perna L; Müller H; Holleczek B; Brenner H
Am J Clin Nutr; 2013 Apr; 97(4):782-93. PubMed ID: 23446902
[TBL] [Abstract][Full Text] [Related]
15. Circulating 25-hydroxyvitamin D concentration and cause-specific mortality in the Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Kvaskoff D; Eyles DW; Giles GG; English DR; Williamson EJ
J Steroid Biochem Mol Biol; 2020 Apr; 198():105612. PubMed ID: 32007563
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study.
Ordóñez-Mena JM; Schöttker B; Haug U; Müller H; Köhrle J; Schomburg L; Holleczek B; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):905-16. PubMed ID: 23462913
[TBL] [Abstract][Full Text] [Related]
17. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
20. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
Rossi E; Hung J; Beilby JP; Knuiman MW; Divitini ML; Bartholomew H
Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
